Author

H. Z. Oo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Churg· 1 shared A. Haegert· 1 shared A. Hurtado-Coll· 1 shared A. Lowy· 1 shared A. McCart· 1 shared A. Molinolo· 1 shared B. McConeghy· 1 shared B. Van Espen· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Churg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential.

B. Van Espen, H. Z. Oo, C. Collins, L. Fazil, A. Molinolo, R. Murad, M. Gleave, Z. A. Ronai

This study shows RNF185 limits prostate cancer migration and metastasis by controlling COL3A1 expression.

bioRxiv · Jun 29, 2023Cancer Biology

BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma

R. Shrestha, N. Nabavi, Y.-Y. Lin, F. Mo, S. Anderson, S. Volik, H. H. Adomat, D. Lin, H. Xue, X. Dong, R. Shukin, R. H. Bell, B. McConeghy, A. Haegert, S. Brahmbhatt, , C. C. Collins

The paper identifies BAP1 loss as a marker for a distinct immunogenic PeM subtype, suggesting potential therapeutic targets like immune checkpoint inhibitors.

bioRxiv · Dec 13, 2018Cancer Biology